Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on equity (ROE) high or low?
The return on equity (ROE) of -56.61% is 23% above its 5-year average of -73.89%, near the high end of its 5-year range (-984.42%–-21.26%).
As of the fiscal period ended Tuesday, June 30, 2026. 20.44% above its 12-month average of -71.16%.
Trailing-twelve-month return on equity at each fiscal quarter end; no daily interpolation. Q2 FY2026 (2026-06-30): -56.61%.
RETURN ON EQUITY (ROE)
-56.61%
RETURN ON EQUITY (ROE) AVG TTM
-71.16%
RETURN ON EQUITY (ROE) AVG 3Y
-66.89%
RETURN ON EQUITY (ROE) AVG 5Y
-73.89%
RETURN ON EQUITY (ROE) AVG 10Y
-83.26%
RETURN ON EQUITY (ROE) AVG 15Y
N/A
RETURN ON EQUITY (ROE) AVG 20Y
N/A
CURRENT VS TTM AVG
+20.44%
CURRENT VS 3Y AVG
+15.36%
CURRENT VS 5Y AVG
+23.38%
CURRENT VS 10Y AVG
+32.00%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-42.01%
median of 753 covered companies
CURRENT VS SECTOR MEDIAN
-34.76%
vs the sector median at left
MediWound Ltd.
Market Cap
$168.92M
Return on Equity (ROE)
-56.61%
TTM Avg
-71.16%
3Y Avg
-66.89%
5Y Avg
-73.89%
Market Cap
$169.53M
Return on Equity (ROE)
-19.01%
TTM Avg
-54.50%
3Y Avg
-75.60%
5Y Avg
-59.28%
Market Cap
$168.10M
Return on Equity (ROE)
-7104.24%
TTM Avg
-166.54%
3Y Avg
-137.65%
5Y Avg
-112.46%
Market Cap
$171.13M
Return on Equity (ROE)
-116.42%
TTM Avg
-18.43%
3Y Avg
-136.68%
5Y Avg
-137.61%
Market Cap
$172.42M
Return on Equity (ROE)
-31.32%
TTM Avg
4.38%
3Y Avg
4.09%
5Y Avg
11.26%
Market Cap
$165.32M
Return on Equity (ROE)
3.51%
TTM Avg
-6.60%
3Y Avg
-9.04%
5Y Avg
-6.71%
Market Cap
$165.27M
Return on Equity (ROE)
-47.36%
TTM Avg
-30.00%
3Y Avg
-33.39%
5Y Avg
-32.72%
Market Cap
$173.76M
Return on Equity (ROE)
-54.27%
TTM Avg
-50.07%
3Y Avg
-62.91%
5Y Avg
-60.87%
Market Cap
$174.27M
Return on Equity (ROE)
-84.80%
TTM Avg
-85.93%
3Y Avg
-69.58%
5Y Avg
-185.12%
| NAME | MARKET CAP | RETURN ON EQUITY (ROE) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| MediWound Ltd. (MDWD) | $168.92M | -56.61% | -71.16% | -66.89% | -73.89% |
| Journey Medical Corporation (DERM)vs › | $169.53M | -19.01% | -54.50% | -75.60% | -59.28% |
| Cue Biopharma, Inc. (CUE)vs › | $168.10M | -7104.24% | -166.54% | -137.65% | -112.46% |
| Precision BioSciences, Inc. (DTIL)vs › | $171.13M | -116.42% | -18.43% | -136.68% | -137.61% |
| Organogenesis Holdings Inc. (ORGO)vs › | $172.42M | -31.32% | 4.38% | 4.09% | 11.26% |
| OptimizeRx Corp. (OPRX)vs › | $165.32M | 3.51% | -6.60% | -9.04% | -6.71% |
| Nkarta, Inc. (NKTX)vs › | $165.27M | -47.36% | -30.00% | -33.39% | -32.72% |
| ProQR Therapeutics N.V. (PRQR)vs › | $173.76M | -54.27% | -50.07% | -62.91% | -60.87% |
| Yarrow Bioscience Inc (YARW)vs › | $174.27M | -84.80% | -85.93% | -69.58% | -185.12% |
| Quanterix Corporation (QTRX)vs › | $162.04M | -51.90% | -23.95% | -20.95% | -18.62% |
ROE
-56.6%
ROA
-28.1%
ROE = Net Income / Total Shareholders' Equity
Return on equity measures how efficiently a company generates profit from shareholders' equity. Higher ROE indicates better capital efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON EQUITY (ROE) |
|---|---|
| 2026-06-30 | -56.61% |
| 2026-03-31 | -63.02% |
| 2025-12-31 | -54.73% |
| 2025-09-30 | -41.08% |
| 2025-06-30 | -140.34% |
| 2025-03-31 | -67.86% |
| 2024-12-31 | -97.02% |
| 2024-09-30 | -81.96% |
| 2024-06-30 | -111.77% |
| 2024-03-31 | -54.97% |
| 2023-12-31 | -21.26% |
| 2023-09-30 | -37.61% |
| 2023-06-30 | -41.32% |
| 2023-03-31 | -59.17% |
| 2022-12-31 | -179.58% |
| 2022-09-30 | -984.42% |
| 2022-03-31 | -734.65% |
| 2021-06-30 | -457.27% |
| 2021-03-31 | -199.04% |
| 2020-12-31 | -126.46% |
| 2020-09-30 | -126.58% |
| 2020-06-30 | -90.88% |
| 2020-03-31 | 51.24% |
| 2019-12-31 | 32.67% |
| 2019-09-30 | 103.73% |
| 2019-06-30 | 89.47% |
| 2019-03-31 | -11.98% |
| 2018-12-31 | -11.78% |
| 2018-03-31 | -445.23% |
| 2017-12-31 | -230.24% |
| 2017-09-30 | -183.87% |
| 2017-03-31 | -513.75% |
| 2016-12-31 | -243.05% |
| 2016-09-30 | -279.26% |
| 2016-06-30 | -163.44% |
| 2016-03-31 | -94.59% |
| 2015-12-31 | -94.11% |
| 2015-09-30 | -70.06% |
| 2015-06-30 | -67.31% |
| 2015-03-31 | -66.05% |
| 2014-12-31 | -44.03% |
| 2014-09-30 | -25.66% |
| 2014-06-30 | -27.93% |
| 2014-03-31 | -22.62% |
